A Conversation About the FDA's Regulation of Mifepristone

Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD, MS, from Johns Hopkins discusses this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content: The US Food and Drug Administration's Regulation of Mifepristone Politics, Science, and the Future of FDA Drug Regulation

You can listen to A Conversation About the FDA's Regulation of Mifepristone online on Radio and Podcast. Open the player on this page to stream the available audio.

A Conversation About the FDA's Regulation of Mifepristone is an episode from JAMA Clinical Reviews: Interviews about ideas & innovations in medicine, science & clinical practice. Listen & earn CME credit by American Medical Association.

This episode is 20:47 long.

This episode was published on Jan 12, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from JAMA Clinical Reviews: Interviews about ideas & innovations in medicine, science & clinical practice. Listen & earn CME credit when more episodes are available from the podcast feed.